Effects of Cannabinoid Receptor Agonist WIN 55,212-2 on Blood-Brain Barrier Disruption in Focal Cerebral Ischemia in Rats

Rimonabant attenuates sensitization, cross-sensitization and cross-reinstatement of place preference induced by nicotine and ethanol

(2014) Grażyna Biała et al.   Pharmacological Reports

Cannabinoid receptor activation modifies NMDA receptor mediated release of intracellular calcium: Implications for endocannabinoid control of hippocampal neural plasticity

(2011) Robert E. Hampson et al.   NEUROPHARMACOLOGY

Modulation of NMDA and AMPA-mediated synaptic transmission by CB1 receptors in frontal cortical pyramidal cells

(2010) Qiang Li et al.   BRAIN RESEARCH

Antagonism of ∆9-THC induced behavioral effects by rimonabant: Time course studies in rats

(2010) Torbjörn U.C. Järbe et al.   EUROPEAN JOURNAL OF PHARMACOLOGY

Effects of GABAA receptor blockade on regional cerebral blood flow and blood–brain barrier disruption in focal cerebral ischemia

(2010) Oak Z. Chi et al.   JOURNAL OF THE NEUROLOGICAL SCIENCES

Evidences of cannabinoids-induced modulation of paroxysmal events in an experimental model of partial epilepsy in the rat

(2009) Valerio Rizzo et al.   NEUROSCIENCE LETTERS

Role of Cannabinoids and Endocannabinoids in Cerebral Ischemia

(2008) Cecilia Hillard   CURRENT PHARMACEUTICAL DESIGN

Modulation of the balance between cannabinoid CB1 and CB2 receptor activation during cerebral ischemic/reperfusion injury

(2008) M. Zhang et al.   NEUROSCIENCE